P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY
In: HemaSphere ; volume 6, page 851-852 ; ISSN 2572-9241, 2022
academicJournal
Zugriff:
Titel: |
P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY
|
---|---|
Autor/in / Beteiligte Person: | Lin, Y. ; Martin, T. ; Berdeja, J. G. ; Jakubowiak, A. ; Agha, M. ; Cohen, A. D. ; Deol, A. ; Htut, M. ; Lesokhin, A. ; Munshi, N. C. ; O’Donnell, E. ; Jackson, C. C. ; Yeh, T. M. ; Banerjee, A. ; Zudaire, E. ; Madduri, D. ; Zhou, C. ; Pacaud, L. ; Usmani, S. Z. ; Jagannath, S. |
Link: | |
Zeitschrift: | HemaSphere ; volume 6, page 851-852 ; ISSN 2572-9241, 2022 |
Veröffentlichung: | Wiley, 2022 |
Medientyp: | academicJournal |
DOI: | 10.1097/01.hs9.0000846712.74284.0f |
Schlagwort: |
|
Sonstiges: |
|